Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.

Murayama, Aki; Sugaya, Keizo; Hara, Makoto; Kawazoe, Tomoya; Tobisawa, Shinsuke; Nakajima, Hideto; Takahashi, Kazushi

Murayama, Aki; Sugaya, Keizo; Hara, Makoto; Kawazoe, Tomoya; Tobisawa, Shinsuke; Nakajima, Hideto; Takahashi, Kazushi.

Afiliação

Murayama A; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Sugaya K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Hara M; Division of Neurology, Department of Medicine, Nihon University School of Medicine, Japan.
Kawazoe T; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Tobisawa S; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Nakajima H; Division of Neurology, Department of Medicine, Nihon University School of Medicine, Japan.
Takahashi K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.

Intern Med ; 62(11): 1659-1663, 2023 Jun 01.

Article em En | MEDLINE | ID: mdl-36223927

Assuntos

Encefalite; Síndrome de Isaacs; Encefalite Límbica; Humanos; Autoanticorpos; Leucina; Síndrome de Isaacs/complicações; Peptídeos e Proteínas de Sinalização Intracelular; Encefalite/diagnóstico; Encefalite/complicações; Encefalite Límbica/complicações; Contactinas

Palavras-chave

Isaacs syndrome; autoantibodies; contactin-associated protein-like 2 (CASPR2); leucine-rich glioma-inactivated 1 (LGI1); limbic encephalitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalite Límbica / Síndrome de Isaacs / Encefalite Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Intern Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google